- Funding Received
- $128 Million in 3 Rounds from 9 Investors
- Most Recent Funding
- $51 Million Series C on August 19, 2014
- Redwood City, CA
- Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.
- Thomas G. Wiggans, Fred craves, Luis Pena, Chris Griffith, Eugene A. Bauer
Dermira is a development-stage, private biotech company focused on developing and commercializing innovative new therapies in dermatology. Dermira was founded by an experienced management team and owns and licenses a robust pipeline of innovative topical compounds addressing areas of need in dermatology. Our lead product candidate, lemuteporfin (LTS), is currently in clinical trials for acne.
Current Team (10)Update
Founder & Chief Medical Officer
Vice President of Engineering
Vice President & Project Management
Founder & CEO
Founder & Vice President, Corporate Development & Strategy
Vice President ofResearch
VP, Pharmaceutical Sciences
Founder & Vice President ofProduct Development
Funding Rounds (3) - $128MUpdate
Bay City Capital LLC (Bay City Capital) was established in 1997 for the purpose of managing...
Global venture capital firm helping entrepreneurs build transformational businesses across...
IT and Healthcare VC
UCB Pharma, a biopharmaceutical and specialty chemical company, develops therapeutics for central...
Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by...
Rock Springs Capital is an investment company located in Baltimore, Maryland. Its advisory...
2055 Woodside Road
Redwood City, CA 94061